InvestSMART

Clover Corporation Limited (ASX: CLV) - Announcements

Current share price for CLV : $1.080 0.1 (10.20%)+

ASX company news and announcements for Clover Corporation Limited (CLV) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Clover Corporation Limited (CLV) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Clover Corporation Limited (CLV), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Clover Corporation Limited (CLV)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$180 Change in substantial shareholding from BKW 12 Sep 2016 3:56PM $0.480 $1.080 risen by 125%
$180 Change in substantial holding from SOL 12 Sep 2016 11:18AM $0.490 $1.080 risen by 120.41%
$180 Change in substantial holding from SOL 12 Sep 2016 9:16AM $0.490 $1.080 risen by 120.41%
$180 Change of Director's Interest Notice 22 Aug 2016 10:48AM $0.460 $1.080 risen by 134.78%
$180 N3RO Clinical Research Study - Initial Results 26 May 2016 8:25AM $0.560 $1.080 risen by 92.86%
$180 Change of Director's Interest Notice 5 May 2016 5:28PM $0.515 $1.080 risen by 109.71%
$180 Change of Director's Interest Notice 4 May 2016 9:09AM $0.520 $1.080 risen by 107.69%
$180 Clover Investor Presentation - Select Equities Conference 2 May 2016 10:29AM $0.460 $1.080 risen by 134.78%
$180 The Good Oil - Clover Corporation March 2016 Newsletter 23 Mar 2016 8:52AM $0.360 $1.080 risen by 200%
$180 Clover Corporation - 1H 2016FY Investor Presentation 23 Mar 2016 8:50AM $0.360 $1.080 risen by 200%
$180 Dividend/Distribution - CLV 23 Mar 2016 8:47AM $0.360 $1.080 risen by 200%
$180 Clover 1H16 Results - new customers drive growth 23 Mar 2016 8:44AM $0.360 $1.080 risen by 200%
$180 Half Yearly Report and Accounts 23 Mar 2016 8:43AM $0.360 $1.080 risen by 200%
$180 Results of Meeting 27 Nov 2015 5:49PM $0.405 $1.080 risen by 166.67%
$180 2015 AGM - Chairman's Address and CEO Presentation 27 Nov 2015 11:05AM $0.570 $1.080 risen by 89.47%
$180 Change in substantial holding 23 Nov 2015 4:35PM $0.500 $1.080 risen by 116%
$180 Payment of final 2015FY Dividend and Policy Change 20 Nov 2015 2:40PM $0.480 $1.080 risen by 125%
$180 Clover 2015 Notice of AGM, Proxy Form & Annual Report 23 Oct 2015 4:12PM $0.350 $1.080 risen by 208.57%
$180 Clover enters Medical Alliance 12 Oct 2015 8:59AM $0.295 $1.080 risen by 266.10%
$180 Company Secretary Appointment/Resignation 25 Sep 2015 4:09PM $0.220 $1.080 risen by 390.91%
$180 2015 Corporate Governance Questionnaire 23 Sep 2015 3:12PM $0.170 $1.080 risen by 535.29%
$180 2015 Annual Report to Shareholders 23 Sep 2015 3:09PM $0.170 $1.080 risen by 535.29%
$180 Dividend/Distribution - CLV 23 Sep 2015 2:44PM $0.170 $1.080 risen by 535.29%
$180 2015 FY Results- Investor Presentation 23 Sep 2015 1:58PM $0.170 $1.080 risen by 535.29%
$180 Clover sales improve despite difficult trading conditions 23 Sep 2015 1:58PM $0.170 $1.080 risen by 535.29%

326 - 350 of 413 results

Page 14 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.